Dimensional Fund Advisors LP Aptinyx Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.38 - $2.58 $53,470 - $363,034	-140,711 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.27 - $3.62 $38,076 - $60,721	16,774 Added 13.53%	140,711 $320,000
Q4 2021 Feb 09, 2022	BUY	$2.11 - $3.0 $12,940 - $18,399	6,133 Added 5.21%	123,937 $331,000
Q3 2021 Nov 12, 2021	SELL	$2.21 - $2.89 $74,271 - $97,124	-33,607 Reduced 22.2%	117,804 $276,000
Q2 2021 Aug 12, 2021	SELL	$2.39 - $3.5 $25,190 - $36,890	-10,540 Reduced 6.51%	151,411 $429,000
Q1 2021 May 14, 2021	BUY	$2.86 - $4.33 $31,388 - $47,521	10,975 Added 7.27%	161,951 $486,000
Q4 2020 Feb 25, 2021	BUY	$2.93 - $4.3 $442,359 - $649,196	150,976 New	150,976 $523,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.